Shuttle Pharmaceuticals (SHPH) - 2022 Q4 - Annual Report

For the transition period from ______________ to ______________ Commission file number:001-41488 UNITED STATES SECURITIES AND EXCHANGE COMMISSION (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 Washington, D.C. 20549 or FORM 10-K ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Shuttle Pharmaceuticals Holdings, Inc. (Exact name of registrant as specified in its charter) Sta ...